Humankind Pharma, increasing insulin accessibility to diabetics, wins Elevation Pitch Competition

For individuals with diabetics, managing blood sugar levels normally means pricking their fingers multiple times a day with a lancet and then placing a drop of blood on a testing strip.

Humankind Pharma, based out of Broomfield, Colorado, is developing a low cost, stable, prefilled insulin syringe to increase the accessibility of injections to diabetics in resource-constrained communities.

While insulin is a life-dependent medication, a century after its initial discovery it is still not reliably accessible to 50% of individuals worldwide whose lives depend on it.

Romi Genosar is the CEO of Humankind Pharma, which was named the winner of the recent Elevation Pitch competition. Her startup’s mission is close to heart, as her commitment was prompted by her own diabetes diagnosis at a young age.

Humankind Pharma provides an advanced prefilled reconstitution syringe that features a low-cost, plastic insulin syringe combined with a specialized cap that features insulin in a dry formulation alongside a diluent in two chambers of a blister package.

The Colorado chapter of the Founder Institute (FI), the world’s largest pre-seed startup accelerator, earlier launched the Elevation Pitch competition aimed at helping entrepreneurs in the Mountain West region improve their ideas and put them into action.

The event, organized in partnership with law firm Bold Legal, was open at no cost to anyone with an idea or startup with less than $10,000 in total revenue or investment.

Judges at the event included:

• Marc Nager, partner at Greater Colorado Venture Fund, co-founder of Startup Weekend, former CEO of UP Global and chief community officer at Techstars
• Peter Adams, executive director at Rockies Venture Club, managing partner at Rockies Venture Fund and Pandemic Impact Fund
• Shea Gerhardt, founder and CEO of Buderflys and PurdyLabs
• Gary Gaessler, Community Builder at Nylas, co-founder of Cloud Elements